Synopsis
Synopsis
0
KDMF
0
VMF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bentyl
2. Bentylol
3. Di Cyclonex
4. Di Spaz
5. Di-cyclonex
6. Di-spaz
7. Dibent
8. Diclomin
9. Dicyclomine
10. Dicycloverin
11. Hydrochloride, Dicyclomine
12. Lomine
13. Merbentyl
14. Or Tyl
15. Or-tyl
16. Spascol
1. 67-92-5
2. Dicyclomine Hcl
3. Dicycloverine Hydrochloride
4. Bentyl
5. Merbentyl
6. Kolantyl Hydrochloride
7. Procyclomin
8. Bentomine
9. Dicyclomine (hydrochloride)
10. Mamiesan
11. Sawamin
12. Atumin
13. Dyspas
14. Oxityl-p
15. Diocyl Hydrochloride
16. Wyovin Hydrochloride
17. Bentylol
18. Wyovin
19. Dicycloverin Hydrochloride
20. 67-92-5 (hcl)
21. 2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate Hydrochloride
22. Mls000028426
23. Mls001074064
24. Cq903kqa31
25. 2-(diethylamino)ethyl (bicyclohexyl)-1-carboxylate Hydrochloride
26. 2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate;hydrochloride
27. Nsc-404381
28. Diethylaminocarbethoxybicyclohexyl Hydrochloride
29. 2-diethylaminoethyl Bicyclohexyl-1-carboxylate Hydrochloride
30. Antispas
31. Benacol
32. Icramin
33. Smr000058440
34. Spasmoject
35. Stannitol
36. Ametil
37. Dibent
38. (bicyclohexyl)-1-carboxylic Acid, 2-(diethylamino)ethyl Ester, Hydrochloride
39. Bis(cyclohexyl)carboxylic Acid Diethylaminoethyl Ester Hydrochloride
40. Beta-diethylaminoethyl 1-cyclohexylcyclohexanecarboxylate Hydrochloride
41. Chebi:4515
42. Bentyl Preservative Free
43. Sr-01000003056
44. Einecs 200-671-1
45. Nsc 404381
46. Unii-cq903kqa31
47. Ai3-18105
48. Dicyclomine Hydrochloride [usp]
49. Prestwick_891
50. Bentyl (tn)
51. Mfcd00079158
52. Opera_id_272
53. Beta-diethylaminoethyl-1-cyclohexylhexahydrobenzoate Hydrochloride
54. Dicyclomine Hydrochloride (preservative-free)
55. Dicyclomine, Hydrochloride
56. Beta-diethylaminoethyl-1-cyclohexylcyclohexanecarboxylate Hydrochloride
57. (1,1'-bicyclohexyl)-1-carboxylic Acid, 2-(diethylamino)ethyl Ester, Hydrochloride
58. 1-cyclohexyl-cyclohexan-1-carbonsaeure-2-diaethylaminoaethylester Hydrochlorid [german]
59. Cloridrato Dell'estere Beta-dietil Aminoetilico Dell'acido Cicloesil-1-cicloesancarbossilico
60. Schembl41670
61. Dicyclominehydrochloride
62. Spectrum1500240
63. Chembl1200479
64. Dtxsid0058778
65. Regid_for_cid_441344
66. Hms1568i17
67. Hms1920e22
68. Pharmakon1600-01500240
69. Dicycloverine For System Suitability
70. Hy-b1339
71. Tox21_500432
72. Ccg-39149
73. Dicyclomine Hydrochloride (jan/usp)
74. Nsc756727
75. Dicyclomine Hydrochloride [mi]
76. (2-(((1,1'-bicyclohexyl)-1-ylcarbonyl)oxy)ethyl)diethylammonium Chloride
77. 1-cyclohexyl-cyclohexan-1-carbonsaeure-2-diaethylaminoaethylester Hydrochlorid
78. Akos015950777
79. Dicyclomine Hydrochloride [jan]
80. Lp00432
81. Nc00504
82. Nsc-756727
83. Dicyclomine Hydrochloride [vandf]
84. Ncgc00093853-01
85. Ncgc00093853-02
86. Ncgc00093853-03
87. Ncgc00093853-04
88. Ncgc00093853-05
89. Ncgc00261117-01
90. Bs-18961
91. Dicyclomine Hydrochloride [usp-rs]
92. Dicycloverine Hydrochloride [mart.]
93. Dicycloverine Hydrochloride [who-dd]
94. Cs-0013089
95. Eu-0100432
96. Ft-0624744
97. Sw197012-3
98. D 7909
99. D00717
100. Dicyclomine Hydrochloride [orange Book]
101. Dicyclomine Hydrochloride [usp Monograph]
102. 067d925
103. Dicyclomine Hydrochloride, >=99% (tlc), Powder
104. Dicycloverine Hydrochloride [ep Monograph]
105. Sr-01000003056-2
106. Sr-01000003056-7
107. Q27106404
108. Diethylaminocarbethoxy-bicyclohexyl Hydrochloride
109. 2-(diethylamino)ethyl Bi(cyclohexane)-1-carboxylate Hydrochloride
110. 2-(diethylamino)ethyl [1,1'-bi(cyclohexane)]-1-carboxylate Hydrochloride
111. 2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate;hydron;chloride
112. Dicycloverine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
113. (1,1'-bicyclohexyl)-1-carboxylic Acid, 2-(diethylamino)ethyl Ester, Hydrochloride (1:1)
114. [1,1'-bicyclohexyl]-1-carboxylic Acid 2-(diethylamino) Ethyl Ester, Hydrochloride
115. 1-cyclohexylhexahydrobenzoic Acid(beta)-diethylaminoethyl Ester Hydrochloride
116. Dicyclomine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 345.9 g/mol |
---|---|
Molecular Formula | C19H36ClNO2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 8 |
Exact Mass | 345.2434571 g/mol |
Monoisotopic Mass | 345.2434571 g/mol |
Topological Polar Surface Area | 29.5 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 326 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 8 | |
---|---|
Drug Name | Bentyl |
Drug Label | Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent. Dicyclomine hydrochloride occurs as a fine, white, crystalline, practically odorless powder with a bitter taste. It is soluble in water, freely soluble in alcoh... |
Active Ingredient | Dicyclomine hydrochloride |
Dosage Form | Injectable; Tablet; Syrup; Capsule |
Route | Injection; Oral |
Strength | 10mg/5ml; 10mg; 10mg/ml; 20mg |
Market Status | Prescription |
Company | Aptalis Pharma Us; Forest Labs |
2 of 8 | |
---|---|
Drug Name | Bentyl preservative free |
Active Ingredient | Dicyclomine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 10mg/ml |
Market Status | Prescription |
Company | Forest Labs |
3 of 8 | |
---|---|
Drug Name | Dicyclomine hydrochloride |
Active Ingredient | Dicyclomine hydrochloride |
Dosage Form | Tablet; Syrup; Capsule |
Route | Oral |
Strength | 10mg/5ml; 10mg; 20mg |
Market Status | Prescription |
Company | Watson Labs; Lannett; Mikart; Mylan |
4 of 8 | |
---|---|
Drug Name | Dicyclomine hydrochloride |
PubMed Health | Dicyclomine |
Drug Classes | Gastrointestinal Agent |
Drug Label | Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent available in the following dosageforms:Dicyclomine Hydrochloride Capsules, USP for oral use contain 10 mg dicyclomine hydrochloride, USP. Dicyclomine hydroch... |
Active Ingredient | Dicyclomine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 10mg/ml |
Market Status | Prescription |
Company | Eurohlth Intl |
5 of 8 | |
---|---|
Drug Name | Bentyl |
Drug Label | Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent. Dicyclomine hydrochloride occurs as a fine, white, crystalline, practically odorless powder with a bitter taste. It is soluble in water, freely soluble in alcoh... |
Active Ingredient | Dicyclomine hydrochloride |
Dosage Form | Injectable; Tablet; Syrup; Capsule |
Route | Injection; Oral |
Strength | 10mg/5ml; 10mg; 10mg/ml; 20mg |
Market Status | Prescription |
Company | Aptalis Pharma Us; Forest Labs |
6 of 8 | |
---|---|
Drug Name | Bentyl preservative free |
Active Ingredient | Dicyclomine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 10mg/ml |
Market Status | Prescription |
Company | Forest Labs |
7 of 8 | |
---|---|
Drug Name | Dicyclomine hydrochloride |
Active Ingredient | Dicyclomine hydrochloride |
Dosage Form | Tablet; Syrup; Capsule |
Route | Oral |
Strength | 10mg/5ml; 10mg; 20mg |
Market Status | Prescription |
Company | Watson Labs; Lannett; Mikart; Mylan |
8 of 8 | |
---|---|
Drug Name | Dicyclomine hydrochloride |
PubMed Health | Dicyclomine |
Drug Classes | Gastrointestinal Agent |
Drug Label | Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent available in the following dosageforms:Dicyclomine Hydrochloride Capsules, USP for oral use contain 10 mg dicyclomine hydrochloride, USP. Dicyclomine hydroch... |
Active Ingredient | Dicyclomine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 10mg/ml |
Market Status | Prescription |
Company | Eurohlth Intl |
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Dicyclomine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dicyclomine Hydrochloride, including repackagers and relabelers. The FDA regulates Dicyclomine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dicyclomine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dicyclomine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dicyclomine Hydrochloride supplier is an individual or a company that provides Dicyclomine Hydrochloride active pharmaceutical ingredient (API) or Dicyclomine Hydrochloride finished formulations upon request. The Dicyclomine Hydrochloride suppliers may include Dicyclomine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Dicyclomine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dicyclomine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Dicyclomine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Dicyclomine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Dicyclomine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dicyclomine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Dicyclomine Hydrochloride USDMF includes data on Dicyclomine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dicyclomine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dicyclomine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dicyclomine Hydrochloride Drug Master File in Japan (Dicyclomine Hydrochloride JDMF) empowers Dicyclomine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dicyclomine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Dicyclomine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dicyclomine Hydrochloride suppliers with JDMF on PharmaCompass.
A Dicyclomine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Dicyclomine Hydrochloride Certificate of Suitability (COS). The purpose of a Dicyclomine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dicyclomine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dicyclomine Hydrochloride to their clients by showing that a Dicyclomine Hydrochloride CEP has been issued for it. The manufacturer submits a Dicyclomine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dicyclomine Hydrochloride CEP holder for the record. Additionally, the data presented in the Dicyclomine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dicyclomine Hydrochloride DMF.
A Dicyclomine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dicyclomine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dicyclomine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Dicyclomine Hydrochloride written confirmation (Dicyclomine Hydrochloride WC) is an official document issued by a regulatory agency to a Dicyclomine Hydrochloride manufacturer, verifying that the manufacturing facility of a Dicyclomine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dicyclomine Hydrochloride APIs or Dicyclomine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Dicyclomine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Dicyclomine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dicyclomine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dicyclomine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dicyclomine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dicyclomine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dicyclomine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dicyclomine Hydrochloride suppliers with NDC on PharmaCompass.
Dicyclomine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dicyclomine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dicyclomine Hydrochloride GMP manufacturer or Dicyclomine Hydrochloride GMP API supplier for your needs.
A Dicyclomine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Dicyclomine Hydrochloride's compliance with Dicyclomine Hydrochloride specifications and serves as a tool for batch-level quality control.
Dicyclomine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Dicyclomine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dicyclomine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Dicyclomine Hydrochloride EP), Dicyclomine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dicyclomine Hydrochloride USP).
LOOKING FOR A SUPPLIER?